RIPK3 and metabolic dysfunction-associated steatohepatitis: Of translational significance, circulating concentrations of RIP1 and RIP3 distinguish patients with AH from healthy controls (HCs), as well as from patients with nonalcoholic steatohepatitis (NASH).